Filter
1719
Filtered Results: 1719
Text search:
World
Health
Organization
(Regional
Office
for
South-East-Asia)
Featured
Recommendations
164
New Publications
441
Language
Document type
No document type
833
Studies & Reports
407
Guidelines
225
Manuals
101
Strategic & Response Plan
69
Training Material
24
Fact sheets
22
Situation Updates
18
Resource Platforms
11
Infographics
5
Brochures
2
Online Courses
2
Countries / Regions
Global
128
South–East Asia Region
73
India
69
Myanmar / Burma
67
Nepal
47
Asia
47
Bangladesh
32
Philippines
30
Western and Central Europe
28
Indonesia
25
Africa
23
Cambodia
20
Ethiopia
17
Uganda
16
Thailand
14
Kenya
14
Western Pacific Region
14
Syria
13
Tanzania
13
Middle East and North Africa
12
South Africa
11
Liberia
11
Pakistan
11
Eastern Europe
10
Afghanistan
9
Zambia
9
Ukraine
8
Ghana
8
Latin America and the Carribbean
8
Sri Lanka
8
China
7
Rwanda
7
Nigeria
7
Laos
7
Malawi
7
Mozambique
7
Haiti
7
West and Central Africa
7
Yemen
7
Congo, Democratic Republic of
6
East and Southern Africa
6
Sierra Leone
5
Senegal
5
Zimbabwe
5
Eastern Europe and Central Asia
5
Vietnam
5
Russia
5
Sudan
5
South Sudan
5
Somalia
5
Timor Leste/ East Timor
4
Iran
4
Venezuela
4
Moldova
4
North Macedonia
3
Turkey
3
Burkina Faso
3
Jordan
3
Papua New Guinea
3
Georgia
3
Central African Republic
3
North Korea
2
Mexico
2
Kazakhstan
2
Albania
2
Malaysia
2
Guinea
2
Belarus
2
Bosnia and Herzegovina
2
Lebanon
2
Namibia
2
Iraq
2
Madagascar
2
Eswatini/ Swaziland
2
Tajikistan
1
Lesotho
1
Cameroon
1
Singapore
1
Kyrgyzstan
1
Peru
1
Vanuatu
1
Morocco
1
Mongolia
1
Qatar
1
Armenia
1
USA
1
Croatia
1
Hungary
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Turkmenistan
1
Japan
1
Belgium
1
Maldives
1
Tunisia
1
Argentina
1
Brazil
1
Djibouti
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Poland
1
Mali
1
Bhutan
1
Botswana
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
419
Clinical Guidelines
180
Public Health
125
Key Resources
125
Women & Child Health
122
Capacity Building
38
Pharmacy & Technologies
19
Toolboxes
HIV
176
Mental Health
136
COVID-19
114
Planetary Health
109
TB
84
NTDs
78
AMR
61
Global Health Education
56
Disability
53
Rapid Response
46
Caregiver
42
Refugee
41
NCDs
36
Natural Hazards
34
Health Financing Toolbox
33
Malaria
30
2.0 Rapid Response
28
Conflict
27
Pharmacy
20
Zika
19
Cholera
12
Ebola & Marburg
12
Polio
10
Specific Hazards
7
Typhoon
3
Social Ethics
1
Meeting report, Kampala, Uganda,
7–8 November 2023
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
This update of the Guidelines for poison control, entitled Guidelines for establishing a poison centre, reflects the development of the role of poison centres in public health and the sound management of chemicals, described in section 1, and the opportunities provided by new technology. Assessments...
WHO Recommendations 2018 Update
The primary audience for these recommendations includes health professionals who are responsible for developing national and local health care guidelines and protocols (particularly those related to PPH prevention and treatment) and those involved in the provision of...
Guidelines for malaria vector control
recommended
Vector control is a vital component of malaria prevention, control and
elimination strategies because it can be highly effective in providing
personal protection and/or reducing disease transmission.
Health Evidence Network synthesis report 53
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes. This document outlines indicators across 4 domains: health system determinants, service delivery, ris...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is important to understand the frequency, characteristics ...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The sixteenth meeting of the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) was held as a hybrid meeting, 27–28 September 2022.
Dr Ren Minghui, Assistant Director-General, Universal Health Coverage/Communicable and Noncommunicable Diseases, welcomed participan...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
Since 1996, trachoma has been targeted for elimination as a public health problem worldwide. The active trachoma criterion for national elimination as a public health problem is a TF1–9 < 5%, sustained for at least two years in the absence of antibiotic mass drug administration (MDA), in each form...
